The order is the third from NSLC in the last four weeks, with the two previous orders for its premium...
Creso Pharma makes strong progress with global growth and cannabis commercialisation strategy
Zoetic International makes rapid progress with CBD business
Zelira Therapeutics accelerates towards commercialisation in 2020
Only registered members can use this feature.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.